Target intelligence / Profile preview

Metal ion chelation

Molecular classification
Other
01

Overview

Metal ion chelation is a chemical process in which a molecule—called a chelating agent or ligand—forms multiple coordinate bonds with a single metal ion, resulting in the formation of a stable ring-like complex known as a chelate. This process is central to coordination chemistry and has significant roles in biology and medicine. In living systems, natural and synthetic chelators regulate essential processes such as nutrient acquisition by microorganisms through siderophores for iron uptake[1], detoxification by binding toxic heavy metals for excretion from the body[3][5], and catalysis within metalloenzymes. Clinically, "metal ion chelation" refers to therapeutic strategies that use drugs like deferoxamine or EDTA to treat conditions involving toxic accumulation of metals such as lead, mercury, iron, or copper. However, "metal ion chelation" itself is not an individual molecular target but rather describes a chemical mechanism; specific targets are usually particular enzymes or proteins involved in these processes. Note on correctness ("is_incorrect"): The entry "Metal ion chelation" does not refer to an individual protein/receptor/target but rather describes a general chemical mechanism/process. Therefore it should not be considered an actionable therapeutic target like an enzyme or receptor; instead it refers broadly to any process involving the binding/sequestration of metal ions by ligands.[3][5]

Other names
ChelationMetal chelationChelating agent activityMetal ion sequestration
02

Mechanism of action

Chelation and sequestration of toxic or excess metal ions to facilitate their excretion from the body[4][7]

03

Biological functions

Regulation of metal ion homeostasisDetoxification of heavy metalsNutrient acquisition (e.g., iron uptake)Catalysis (as in metalloenzymes)Analytical detection of metal ions
04

Disease associations

Heavy metal poisoningIron overload disorders (e.g., hemochromatosis)Wilson’s disease (copper overload)Other
05

Safety considerations

Potential depletion of essential metals/minerals[4]Nephrotoxicity with some agents such as EDTA[4]Allergic reactions or adverse effects depending on the chelator used[4]
06

Interacting drugs

Deferoxamine

4 more in the full profile.

Beyond the preview

Go deeper on Metal ion chelation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metal ion chelation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call